STATE STREET CORP - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$60,639,849
+2.3%
867,647
+5.1%
0.00%0.0%
Q2 2023$59,298,082
+20.8%
825,189
+3.7%
0.00%0.0%
Q1 2023$49,100,056
-57.9%
796,045
-47.4%
0.00%0.0%
Q4 2022$116,754,766
+267.8%
1,513,740
+112.8%
0.00%
+50.0%
Q3 2022$31,740,000
-2.8%
711,332
-16.6%
0.00%0.0%
Q2 2022$32,669,000
+12.9%
852,983
+22.0%
0.00%
+100.0%
Q1 2022$28,932,000
+2.7%
699,006
-6.3%
0.00%0.0%
Q4 2021$28,180,000
+8.8%
745,907
-5.0%
0.00%0.0%
Q3 2021$25,892,000
-40.0%
785,573
+22.8%
0.00%
-50.0%
Q2 2021$43,158,000
+21.2%
639,757
+1.7%
0.00%0.0%
Q1 2021$35,623,000
-32.1%
629,168
-2.2%
0.00%
-33.3%
Q4 2020$52,435,000
+12.5%
643,617
-1.6%
0.00%0.0%
Q3 2020$46,593,000
-21.4%
653,934
-9.3%
0.00%
-25.0%
Q2 2020$59,301,000
+52.4%
720,726
+9.0%
0.00%
+33.3%
Q1 2020$38,905,000
-40.2%
661,315
+5.0%
0.00%
-25.0%
Q4 2019$65,083,000
+340.7%
629,676
-13.7%
0.00%
+300.0%
Q3 2019$14,769,000
-12.0%
729,682
+12.0%
0.00%0.0%
Q2 2019$16,775,000
+8502.6%
651,473
+4655.3%
0.00%
Q1 2019$195,000
-63.9%
13,700
-90.1%
0.00%
Q1 2017$540,000
-40.5%
138,188
+2.6%
0.00%
Q4 2016$908,000
-8.8%
134,688
+6.7%
0.00%
Q3 2016$996,000
+16.4%
126,222
+11.2%
0.00%
Q2 2016$856,000113,4910.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,008,508$82,980,00048.53%
Fairmount Funds Management LLC 216,098$17,781,0007.93%
WMS Partners, LLC 250,000$20,570,0004.26%
RTW INVESTMENTS, LP 1,658,316$136,446,0003.84%
MORGAN JESS S & CO INC 39,328$3,236,0003.51%
RA Capital Management 2,035,132$167,451,0003.26%
Ghost Tree Capital, LLC 100,000$8,228,0002.17%
ACUTA CAPITAL PARTNERS, LLC 90,000$7,405,0002.14%
Avidity Partners Management LP 404,900$33,315,0002.14%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,085,836$89,343,0001.97%
View complete list of AXSOME THERAPEUTICS INC shareholders